Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

[Contribution of hyperandrogenism to the development of metabolic syndrome in obese women with polycystic ovary syndrome].

Rehme MF, Pontes AG, Corrente JE, Franco JG Jr, Pontes A.

Rev Bras Ginecol Obstet. 2013 Dec;35(12):562-8. Portuguese.

2.

Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.

Amato MC, Galluzzo A, Merlino S, Mattina A, Richiusa P, Criscimanna A, Giordano C.

Eur J Endocrinol. 2006 Dec;155(6):859-65.

3.
4.
5.

Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study.

Zhang HY, Guo CX, Zhu FF, Qu PP, Lin WJ, Xiong J.

Arch Gynecol Obstet. 2013 Mar;287(3):525-31. doi: 10.1007/s00404-012-2568-z. Epub 2012 Oct 30.

PMID:
23108387
6.

Prevalence of metabolic syndrome is higher among non-obese PCOS women with hyperandrogenism and menstrual irregularity in Korea.

Kim MJ, Lim NK, Choi YM, Kim JJ, Hwang KR, Chae SJ, Park CW, Choi DS, Kang BM, Lee BS, Kim T, Park HY.

PLoS One. 2014 Jun 5;9(6):e99252. doi: 10.1371/journal.pone.0099252. eCollection 2014.

7.

[Exploration of the classification of polycystic ovarian syndrome].

Lin JF, Li X, Zhu MW.

Zhonghua Fu Chan Ke Za Zhi. 2006 Oct;41(10):684-8. Chinese.

PMID:
17199924
8.

Dyslipidaemia in polycystic ovarian syndrome: different groups, different aetiologies?

Meirow D, Raz I, Yossepowitch O, Brzezinski A, Rosler A, Schenker JG, Berry EM.

Hum Reprod. 1996 Sep;11(9):1848-53.

9.

Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.

Wu J, Zhu Y, Jiang Y, Cao Y.

Gynecol Endocrinol. 2008 Jul;24(7):392-8. doi: 10.1080/09513590802217027.

PMID:
18608522
10.

Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.

Becerra-Fernández A, Pérez-López G, Román MM, Martín-Lazaro JF, Lucio Pérez MJ, Asenjo Araque N, Rodríguez-Molina JM, Berrocal Sertucha MC, Aguilar Vilas MV.

Endocrinol Nutr. 2014 Aug-Sep;61(7):351-8. doi: 10.1016/j.endonu.2014.01.010. Epub 2014 Mar 26. English, Spanish.

PMID:
24680383
11.

Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.

Espinós-Gómez JJ, Rodriguez-Espinosa J, Ordóñez-Llanos J, Calaf-Alsina J.

Gynecol Endocrinol. 2012 Apr;28(4):264-8. doi: 10.3109/09513590.2011.613968. Epub 2011 Oct 1.

PMID:
21962027
12.

Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome.

Huang R, Zheng J, Li S, Tao T, Ma J, Liu W.

Acta Obstet Gynecol Scand. 2015 May;94(5):494-500. doi: 10.1111/aogs.12612. Epub 2015 Mar 19.

PMID:
25711494
13.

Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome.

Alpañés M, Luque-Ramírez M, Martínez-García MÁ, Fernández-Durán E, Álvarez-Blasco F, Escobar-Morreale HF.

Fertil Steril. 2015 Mar;103(3):795-801.e2. doi: 10.1016/j.fertnstert.2014.12.105. Epub 2015 Jan 10.

PMID:
25585504
14.

Plasma selenium levels in Turkish women with polycystic ovary syndrome.

Coskun A, Arikan T, Kilinc M, Arikan DC, Ekerbiçer HÇ.

Eur J Obstet Gynecol Reprod Biol. 2013 Jun;168(2):183-6. doi: 10.1016/j.ejogrb.2013.01.021. Epub 2013 Mar 13.

PMID:
23490536
15.

The insulin-resistant phenotype of polycystic ovary syndrome.

Svendsen PF, Madsbad S, Nilas L.

Fertil Steril. 2010 Aug;94(3):1052-8. doi: 10.1016/j.fertnstert.2009.04.008. Epub 2009 Jul 5.

PMID:
19580964
16.

Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.

Alemzadeh R, Kichler J, Calhoun M.

Eur J Endocrinol. 2010 Jun;162(6):1093-9. doi: 10.1530/EJE-10-0205. Epub 2010 Apr 6.

17.

Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.

Lam UD, Lerchbaum E, Schweighofer N, Trummer O, Eberhard K, Genser B, Pieber TR, Obermayer-Pietsch B.

Gene. 2014 Mar 10;537(2):245-52. doi: 10.1016/j.gene.2013.12.055. Epub 2014 Jan 2.

PMID:
24388959
18.

Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.

Tziomalos K, Katsikis I, Papadakis E, Kandaraki EA, Macut D, Panidis D.

Hum Reprod. 2013 Mar;28(3):785-93. doi: 10.1093/humrep/des456. Epub 2013 Jan 12.

20.

Adrenal androgen excess and body mass index in polycystic ovary syndrome.

Moran C, Arriaga M, Arechavaleta-Velasco F, Moran S.

J Clin Endocrinol Metab. 2015 Mar;100(3):942-50. doi: 10.1210/jc.2014-2569. Epub 2014 Dec 16.

PMID:
25514100
Items per page

Supplemental Content

Write to the Help Desk